Home/SEC 13D/G/KLRASEC 13D/GKLRA - Kailera Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified$KLRA$18.47▼ -29.04% YTDHealthcareAug 14, 2026 · ThinkSabio BlogSEC Filing Update: #KLRA Kailera Therapeutics, Inc. : $18.47 Sector: Healthcare | YTD: 🔽 -29.04% The SEC disclosed Today (14-AUG-2026) that RTW INVESTMENTS LP has Newly bought 10,776,820 #KLRA shares Ownership: 8.3% * Estimated Investment Value: $197.97M https://www.thinksabio.com/reports/isr/KLRA 📌 Institutional activity in the last 30 days for #KLRA: • Jiangsu Hengrui Pharmaceuticals Co., Ltd. – Newly bought 11,511,853 shares (05-AUG-2026) Share this post🔗Copy LinkMore filings for $KLRAKLRA SEC Filing Update (05-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 5, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G